| Year |
Citation |
Score |
| 2017 |
Regan JN, Mikesell C, Reiken S, Xu H, Marks AR, Mohammad KS, Guise TA, Waning DL. Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model. Frontiers in Endocrinology. 8: 358. PMID 29312148 DOI: 10.3389/Fendo.2017.00358 |
0.353 |
|
| 2017 |
Regan JN, Trivedi T, Guise TA, Waning DL. The Role of TGFβ in Bone-Muscle Crosstalk. Current Osteoporosis Reports. PMID 28161871 DOI: 10.1007/S11914-017-0344-5 |
0.35 |
|
| 2016 |
Wright LE, Harhash AA, Kozlow WM, Waning DL, Regan JN, She Y, John SK, Murthy S, Niewolna M, Marks AR, Mohammad KS, Guise TA. Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo. Oncotarget. PMID 28039445 DOI: 10.18632/Oncotarget.14139 |
0.344 |
|
| 2016 |
Majesky MW, Horita H, Ostriker A, Lu S, Regan JN, Bagchi AK, Dong XR, Poczobutt JM, Nemenoff RA, Weiser-Evans MC. Differentiated Smooth Muscle Cells Generate a Subpopulation of Resident Vascular Progenitor Cells in the Adventitia Regulated by KLF4. Circulation Research. PMID 27834190 DOI: 10.1161/Circresaha.116.309322 |
0.592 |
|
| 2016 |
Regan J, Waning D, Mohammad K, Mikesell C, Reiken S, Marks A, Guise T. Muscle dysfunction in immune competent mice with osteolytic breast cancer in bone is associated with skeletal muscle oxidation of RyR1 Bone Abstracts. DOI: 10.1530/Boneabs.5.Cabs.Oc4.1 |
0.324 |
|
| 2015 |
Regan JN, Waning DL, Guise TA. Skeletal muscle Ca(2+) mishandling: another effect of bone-to-muscle signaling. Seminars in Cell & Developmental Biology. PMID 26593325 DOI: 10.1016/J.Semcdb.2015.11.007 |
0.36 |
|
| 2014 |
Regan JN, Lim J, Shi Y, Joeng KS, Arbeit JM, Shohet RV, Long F. Up-regulation of glycolytic metabolism is required for HIF1α-driven bone formation. Proceedings of the National Academy of Sciences of the United States of America. 111: 8673-8. PMID 24912186 DOI: 10.1073/Pnas.1324290111 |
0.331 |
|
| 2014 |
Chen J, Shi Y, Regan J, Karuppaiah K, Ornitz DM, Long F. Osx-Cre targets multiple cell types besides osteoblast lineage in postnatal mice. Plos One. 9: e85161. PMID 24454809 DOI: 10.1371/Journal.Pone.0085161 |
0.359 |
|
| 2013 |
Wu SP, Dong XR, Regan JN, Su C, Majesky MW. Tbx18 regulates development of the epicardium and coronary vessels. Developmental Biology. 383: 307-20. PMID 24016759 DOI: 10.1016/J.Ydbio.2013.08.019 |
0.58 |
|
| 2013 |
Regan J, Long F. Notch signaling and bone remodeling. Current Osteoporosis Reports. 11: 126-9. PMID 23519781 DOI: 10.1007/S11914-013-0145-4 |
0.378 |
|
| 2012 |
Duan J, Gherghe C, Liu D, Hamlett E, Srikantha L, Rodgers L, Regan JN, Rojas M, Willis M, Leask A, Majesky M, Deb A. Wnt1/βcatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. The Embo Journal. 31: 429-42. PMID 22085926 DOI: 10.1038/Emboj.2011.418 |
0.512 |
|
| 2011 |
Majesky MW, Dong XR, Regan JN, Hoglund VJ. Vascular smooth muscle progenitor cells: building and repairing blood vessels. Circulation Research. 108: 365-77. PMID 21293008 DOI: 10.1161/Circresaha.110.223800 |
0.609 |
|
| 2010 |
Huang ZP, Chen JF, Regan JN, Maguire CT, Tang RH, Dong XR, Majesky MW, Wang DZ. Loss of microRNAs in neural crest leads to cardiovascular syndromes resembling human congenital heart defects. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 2575-86. PMID 20884876 DOI: 10.1161/Atvbaha.110.213306 |
0.529 |
|
| 2009 |
Regan JN, Majesky MW. Building a vessel wall with notch signaling. Circulation Research. 104: 419-21. PMID 19246684 DOI: 10.1161/Circresaha.109.194233 |
0.595 |
|
| Show low-probability matches. |